Nikola Ivetic

440 total citations
21 papers, 298 citations indexed

About

Nikola Ivetic is a scholar working on Hematology, Surgery and Emergency Medicine. According to data from OpenAlex, Nikola Ivetic has authored 21 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 13 papers in Surgery and 7 papers in Emergency Medicine. Recurrent topics in Nikola Ivetic's work include Platelet Disorders and Treatments (17 papers), Heparin-Induced Thrombocytopenia and Thrombosis (12 papers) and Intramuscular injections and effects (7 papers). Nikola Ivetic is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Heparin-Induced Thrombocytopenia and Thrombosis (12 papers) and Intramuscular injections and effects (7 papers). Nikola Ivetic collaborates with scholars based in Canada, United States and Germany. Nikola Ivetic's co-authors include Donald M. Arnold, John G. Kelton, James W. Smith, Ishac Nazy, Jane C. Moore, Ishac Nazi, Rumi Clare, Patricia C. Liaw, Dhruva J. Dwivedi and Lisa J. Toltl and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Blood.

In The Last Decade

Nikola Ivetic

19 papers receiving 295 citations

Peers

Nikola Ivetic

HEMAT

SURGE

PRM

PHYSI

Aron Flagg United States

Rumi Clare Canada

Durjoy K. Shome Bahrain

B. Godeau France

Guillaume Denis France

Penelope Motum Australia

G. R. Hazlehurst United Kingdom

B Amor France

Renu Regunathan-Shenk United States

Chisaki Mizumoto Japan

Aron Flagg United States

Nikola Ivetic

38 ×0.2

HEMAT

69 ×0.8

SURGE

19 ×0.2

PRM

24 ×0.3

PHYSI

38 ×0.9

Citations per year, relative to Nikola Ivetic Nikola Ivetic (= 1×) peers Aron Flagg

Countries citing papers authored by Nikola Ivetic

Since Specialization

Citations

This map shows the geographic impact of Nikola Ivetic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikola Ivetic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikola Ivetic more than expected).

Fields of papers citing papers by Nikola Ivetic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikola Ivetic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikola Ivetic. The network helps show where Nikola Ivetic may publish in the future.

Co-authorship network of co-authors of Nikola Ivetic

This figure shows the co-authorship network connecting the top 25 collaborators of Nikola Ivetic. A scholar is included among the top collaborators of Nikola Ivetic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikola Ivetic. Nikola Ivetic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clare, Rumi, Yi Zhang, Nikola Ivetic, et al.. (2025). Persistence of anti-platelet factor 4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis for 3 years. Journal of Thrombosis and Haemostasis. 23(12). 3958–3964.

Ivetic, Nikola, Yi Zhang, Rumi Clare, et al.. (2025). Monoclonal Antibodies in the Pathogenesis of Heparin-Induced Thrombocytopenia. New England Journal of Medicine. 393(9). 879–886.

Nguyen, Son, et al.. (2024). Structural Characterization of a Pathogenic Antibody Underlying Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT). Analytical Chemistry. 96(16). 6209–6217. 4 indexed citations

Ivetic, Nikola, et al.. (2023). Reverse Engineering of a Pathogenic Antibody Reveals the Molecular Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia. Journal of the American Chemical Society. 145(46). 25203–25213. 9 indexed citations

Hack, Maureen, Ying Zhang, Rumi Clare, et al.. (2023). PB0343 Longitudinal Study on the Persistence of Anti-Platelet Factor 4 Antibodies in Vaccine-Induced Immune Thrombotic Thrombocytopenia after 14 Months. Research and Practice in Thrombosis and Haemostasis. 7. 101485–101485. 1 indexed citations

Huynh, Angela, Donald M. Arnold, Nikola Ivetic, et al.. (2023). Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis. 21(10). 2833–2843. 12 indexed citations

Jevtic, Stefan D., et al.. (2022). Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis. Frontiers in Cardiovascular Medicine. 9. 1040196–1040196. 4 indexed citations

Daka, Mercy, Donald M. Arnold, James W. Smith, et al.. (2022). The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Advances. 6(14). 4228–4235. 19 indexed citations

Appelbaum, Jacob, Donald M. Arnold, John G. Kelton, et al.. (2021). SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia. Blood Advances. 6(7). 2250–2253. 13 indexed citations

10.

Huynh, Angela, Donald M. Arnold, James W. Smith, et al.. (2021). Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Viruses. 13(4). 697–697. 19 indexed citations

11.

Huynh, Angela, Donald M. Arnold, James W. Smith, et al.. (2020). The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia. Thrombosis Research. 194. 135–141. 4 indexed citations

12.

Ivetic, Nikola, Donald M. Arnold, James W. Smith, et al.. (2019). A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia. Platelets. 30(8). 1017–1021. 6 indexed citations

13.

Nazy, Ishac, John G. Kelton, Jane C. Moore, et al.. (2018). Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia. British Journal of Haematology. 181(2). 234–241. 15 indexed citations

14.

Nazy, Ishac, Lisa J. Toltl, Catherine Ross, et al.. (2018). Megakaryocyte apoptosis in immune thrombocytopenia. Platelets. 29(7). 729–732. 32 indexed citations

15.

Arnold, Donald M., James W. Smith, Yang Liu, et al.. (2017). The effect of rituximab on anti‐platelet autoantibody levels in patients with immune thrombocytopenia. British Journal of Haematology. 178(2). 302–307. 31 indexed citations

16.

Qadri, Syed M., Varsha Bhakta, Louise J. Eltringham‐Smith, et al.. (2016). Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin. Journal of Cellular and Molecular Medicine. 20(4). 710–720. 77 indexed citations

17.

Ivetic, Nikola, Ishac Nazi, Rumi Clare, et al.. (2016). Producing megakaryocytes from a human peripheral blood source. Transfusion. 56(5). 1066–1074. 10 indexed citations

18.

Nazy, Ishac, Jane C. Moore, Rumi Clare, et al.. (2016). Autoantibodies to Thrombopoietin and the Thrombopoietin Receptor in Patients with Immune Thrombocytopenia. Blood. 128(22). 2548–2548. 4 indexed citations

19.

Arnold, Donald M., Ishac Nazi, Lisa J. Toltl, et al.. (2015). Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia. European Journal Of Haematology. 95(6). 532–537. 13 indexed citations

20.

Nazi, Ishac, Donald M. Arnold, Jane C. Moore, et al.. (2015). Pitfalls in the diagnosis of heparin‐Induced thrombocytopenia: A 6‐year experience from a reference laboratory. American Journal of Hematology. 90(7). 629–633. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact